Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-center, Open-label, Ascending Single- and Multiple-oral Dose Study to Evaluate the Pharmacokinetics and Safety of Ranolazine PR in Healthy Korean and Caucasian Male Subjects

NCT02817932 is registered in ClinicalTrials.gov with A.Menarini Asia-Pacific Holdings Pte Ltd as lead sponsor.

NCT NCT02817932
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02817932 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-center, Open-label, Ascending Single- and Multiple-oral Dose Study to Evaluate the Pharmacokinetics and Safety of Ranolazine PR in Healthy Korean and Caucasian Male Subjects
Lead sponsor
A.Menarini Asia-Pacific Holdings Pte Ltd
Phase
Phase 1
Overall status
Unknown status
Start date
March 31, 2016
Completion date
October 31, 2016
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy male individuals